{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:44:22Z","timestamp":1767174262679,"version":"build-2238731810"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Innovation Joint Fund Project of Fujian Province","award":["2019Y9044"],"award-info":[{"award-number":["2019Y9044"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2020J011131"],"award-info":[{"award-number":["2020J011131"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      In our previous study it was found that\n                      <jats:italic>CENPL<\/jats:italic>\n                      was overexpressed in hepatocellular carcinoma and significantly predicted patient's prognosis. However, the expression and prognostic value of\n                      <jats:italic>CENPL<\/jats:italic>\n                      in other gastrointestinal tumors remain unknown. Therefore, we investigated the expression and prognostic value of\n                      <jats:italic>CENPL<\/jats:italic>\n                      in esophageal carcinoma (ESCA), stomach adenocarcinoma (STAD), pancreatic adenocarcinoma (PAAD), colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this study, Oncomine, GEPIA, OncoLnc, TIMER, cBioPortal, miRWalk and ENCORI databases were used to analyze the level of\n                      <jats:italic>CENPL<\/jats:italic>\n                      mRNA, prognostic value and potential regulatory mechanism of\n                      <jats:italic>CENPL<\/jats:italic>\n                      mRNA in tumors. The\n                      <jats:italic>CENPL<\/jats:italic>\n                      expression and clinicopathological data regarding PAAD were from the UCSC Xena database and univariate and multivariate Cox regression analyses were performed using R (Version 3.6.3). Immunohistochemical staining was used to verify the expression of CENPL protein in clinical specimens. Cytoscape (Version: 3.7.2) was used to visualize microRNA (miRNA) that potentially regulates\n                      <jats:italic>CENPL<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Gene differential expression analysis showed that\n                      <jats:italic>CENPL<\/jats:italic>\n                      mRNA was significantly overexpressed in ESCA, STAD, PAAD, COAD and READ (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). The overexpression of\n                      <jats:italic>CENPL<\/jats:italic>\n                      mRNA was significantly correlated with the poor prognosis of PAAD patients (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). However, there was no significant correlation between the level of\n                      <jats:italic>CENPL<\/jats:italic>\n                      mRNA and the prognosis of ESCA, STAD, COAD and READ patients (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05). Univariate and multivariate Cox regression analyses suggested that\n                      <jats:italic>CENPL<\/jats:italic>\n                      was a prognostic risk factor for PAAD. The mutation rate of\n                      <jats:italic>CENPL<\/jats:italic>\n                      in PAAD was 2.2% (17\/850). There was no significant correlation between the\n                      <jats:italic>CENPL<\/jats:italic>\n                      expression and the infiltration levels of immune cells in PAAD (|Cor|&lt;\u20090.5). Immunohistochemical staining showed that CENPL was overexpressed in 42% (11\/26) of PAAD specimens, which was significantly higher compared with that in the normal tissues. The expression of miR-340-3p and miR-484 in PAAD were significantly lower than in the normal tissues (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) and PAAD patients with lower expression of miR-340-3p had poorer prognosis (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CENPL potentially regulated by miR-340-3p, is overexpressed in PAAD and predicts patient\u2019s prognosis, suggestive of a diagnostic and prognostic value in PAAD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-022-10450-5","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T16:02:47Z","timestamp":1672070567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Zhongyuan","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jielong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongzhuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiehong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasha","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanfang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,26]]},"reference":[{"issue":"6","key":"10450_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10450_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","volume":"159","author":"M Arnold","year":"2020","unstructured":"Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, et al. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. 2020;159(1):335-49 e15.","journal-title":"Gastroenterology"},{"issue":"3","key":"10450_CR3","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB. Burden of Gastric Cancer. Clin Gastroenterol Hepatol. 2020;18(3):534\u201342.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10450_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145\u201364.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10450_CR5","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cgh.2020.02.026","volume":"19","author":"MCS Wong","year":"2021","unstructured":"Wong MCS, Huang J, Lok V, Wang J, Fung F, Ding H, et al. Differences in Incidence and Mortality Trends of Colorectal Cancer Worldwide Based on Sex, Age, and Anatomic Location. Clin Gastroenterol Hepatol. 2021;19(5):955-66 e61.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10450_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1053\/j.gastro.2020.10.007","volume":"160","author":"J Huang","year":"2021","unstructured":"Huang J, Lok V, Ngai CH, Zhang L, Yuan J, Lao XQ, et al. Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer. Gastroenterology. 2021;160(3):744\u201354.","journal-title":"Gastroenterology"},{"key":"10450_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102030","volume":"88","author":"M Abdul-Latif","year":"2020","unstructured":"Abdul-Latif M, Townsend K, Dearman C, Shiu KK, Khan K. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectives. Cancer Treat Rev. 2020;88: 102030.","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"10450_CR8","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-020-1063-5","volume":"26","author":"Y Nakamura","year":"2020","unstructured":"Nakamura Y, Taniguchi H, Ikeda M, Bando H, Kato K, Morizane C, et al. Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies. Nat Med. 2020;26(12):1859\u201364.","journal-title":"Nat Med"},{"key":"10450_CR9","first-page":"6651397","volume":"2021","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wu Z, Peng Y, Li D, Jiang Y, Pan F, et al. Correlationship between Ki67, VEGF, and p53 and Hepatocellular Carcinoma Recurrence in Liver Transplant Patients. Biomed Res Int. 2021;2021:6651397.","journal-title":"Biomed Res Int"},{"issue":"15","key":"10450_CR10","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s00018-020-03472-4","volume":"77","author":"M Hara","year":"2020","unstructured":"Hara M, Fukagawa T. Dynamics of kinetochore structure and its regulations during mitotic progression. Cell Mol Life Sci. 2020;77(15):2981\u201395.","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"10450_CR11","doi-asserted-by":"publisher","first-page":"R487","DOI":"10.1016\/j.cub.2016.05.031","volume":"26","author":"LE Kursel","year":"2016","unstructured":"Kursel LE, Malik HS. Centromeres. Curr Biol. 2016;26(12):R487\u201390.","journal-title":"Curr Biol"},{"issue":"6","key":"10450_CR12","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.molcel.2015.10.027","volume":"60","author":"KL McKinley","year":"2015","unstructured":"McKinley KL, Sekulic N, Guo LY, Tsinman T, Black BE, Cheeseman IM. The CENP-L-N Complex Forms a Critical Node in an Integrated Meshwork of Interactions at the Centromere-Kinetochore Interface. Mol Cell. 2015;60(6):886\u201398.","journal-title":"Mol Cell"},{"issue":"Pt 4","key":"10450_CR13","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1242\/jcs.091967","volume":"125","author":"N McHedlishvili","year":"2012","unstructured":"McHedlishvili N, Wieser S, Holtackers R, Mouysset J, Belwal M, Amaro AC, et al. Kinetochores accelerate centrosome separation to ensure faithful chromosome segregation. J Cell Sci. 2012;125(Pt 4):906\u201318.","journal-title":"J Cell Sci"},{"issue":"1","key":"10450_CR14","doi-asserted-by":"publisher","first-page":"15610","DOI":"10.1038\/s41598-021-95068-6","volume":"11","author":"J Yin","year":"2021","unstructured":"Yin J, Lin C, Jiang M, Tang X, Xie D, Chen J, et al. CENPL, ISG20L2, LSM4, MRPL3 are four novel hub genes and may serve as diagnostic and prognostic markers in breast cancer. Sci Rep. 2021;11(1):15610.","journal-title":"Sci Rep"},{"key":"10450_CR15","doi-asserted-by":"publisher","first-page":"9971799","DOI":"10.1155\/2021\/9971799","volume":"2021","author":"Z Cui","year":"2021","unstructured":"Cui Z, Xiao L, Chen F, Wang J, Lin H, Li D, et al. High mRNA Expression of CENPL and Its Significance in Prognosis of Hepatocellular Carcinoma Patients. Dis Markers. 2021;2021:9971799.","journal-title":"Dis Markers"},{"issue":"1","key":"10450_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6(1):1\u20136.","journal-title":"Neoplasia"},{"issue":"W1","key":"10450_CR17","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"10450_CR18","doi-asserted-by":"publisher","DOI":"10.7717\/peerj-cs.67","volume":"2","author":"JA OncoLnc","year":"2016","unstructured":"OncoLnc JA. linking TCGA survival data to mRNAs, miRNAs, and lncRNAs. PeerJ Computer Science. 2016;2: e67. https:\/\/doi.org\/10.7717\/peerj-cs.67.","journal-title":"PeerJ Computer Science"},{"issue":"8","key":"10450_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017;19(8):649\u201358.","journal-title":"Neoplasia"},{"issue":"6","key":"10450_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repecka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10450_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"21","key":"10450_CR22","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"issue":"10","key":"10450_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht C, De La Torre C, Parveen A, Gretz N. miRWalk: An online resource for prediction of microRNA binding sites. PLoS ONE. 2018;13(10): e0206239.","journal-title":"PLoS ONE"},{"key":"10450_CR24","doi-asserted-by":"crossref","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92\u20137.","DOI":"10.1093\/nar\/gkt1248"},{"issue":"20","key":"10450_CR25","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical A","year":"2013","unstructured":"World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134.","journal-title":"JAMA"},{"key":"10450_CR26","first-page":"8052212","volume":"2022","author":"L Yang","year":"2022","unstructured":"Yang L, Ning Q, Tang SS. Recent Advances and Next Breakthrough in Immunotherapy for Cancer Treatment. J Immunol Res. 2022;2022:8052212.","journal-title":"J Immunol Res"},{"issue":"5","key":"10450_CR27","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.cgh.2020.02.054","volume":"19","author":"N Khalaf","year":"2021","unstructured":"Khalaf N, El-Serag HB, Abrams HR, Thrift AP. Burden of Pancreatic Cancer: From Epidemiology to Practice. Clin Gastroenterol Hepatol. 2021;19(5):876\u201384.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10450_CR28","doi-asserted-by":"crossref","unstructured":"Weissmueller S, Manchado E, Saborowski M, Morris JPt, Wagenblast E, Davis CA, et al. Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor beta signaling. Cell. 2014;157(2):382\u201394.","DOI":"10.1016\/j.cell.2014.01.066"},{"issue":"1","key":"10450_CR29","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1073\/pnas.0908428107","volume":"107","author":"JP Morton","year":"2010","unstructured":"Morton JP, Timpson P, Karim SA, Ridgway RA, Athineos D, Doyle B, et al. Mutant p53 drives metastasis and overcomes growth arrest\/senescence in pancreatic cancer. Proc Natl Acad Sci U S A. 2010;107(1):246\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"35","key":"10450_CR30","doi-asserted-by":"publisher","first-page":"17450","DOI":"10.1073\/pnas.1901765116","volume":"116","author":"S Hashimoto","year":"2019","unstructured":"Hashimoto S, Furukawa S, Hashimoto A, Tsutaho A, Fukao A, Sakamura Y, et al. ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer. Proc Natl Acad Sci U S A. 2019;116(35):17450\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10450_CR31","doi-asserted-by":"crossref","first-page":"175883592110337","DOI":"10.1177\/17588359211033704","volume":"13","author":"F van der Sijde","year":"2021","unstructured":"van der Sijde F, Azmani Z, Besselink MG, Bonsing BA, de Groot JWB, Groot Koerkamp B, et al. Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX. Ther Adv Med Oncol. 2021;13:17588359211033704.","journal-title":"Ther Adv Med Oncol"},{"issue":"6","key":"10450_CR32","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ceb.2005.09.012","volume":"17","author":"KW Yuen","year":"2005","unstructured":"Yuen KW, Montpetit B, Hieter P. The kinetochore and cancer: what\u2019s the connection? Curr Opin Cell Biol. 2005;17(6):576\u201382.","journal-title":"Curr Opin Cell Biol"},{"issue":"8","key":"10450_CR33","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1111\/cas.14989","volume":"112","author":"M Jo","year":"2021","unstructured":"Jo M, Kusano Y, Hirota T. Unraveling pathologies underlying chromosomal instability in cancers. Cancer Sci. 2021;112(8):2975\u201383.","journal-title":"Cancer Sci"},{"issue":"9","key":"10450_CR34","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.210189","volume":"11","author":"Q Dong","year":"2021","unstructured":"Dong Q, Yang J, Gao J, Li F. Recent insights into mechanisms preventing ectopic centromere formation. Open Biol. 2021;11(9): 210189.","journal-title":"Open Biol"},{"key":"10450_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2015.05.001","volume":"87","author":"SM Hammond","year":"2015","unstructured":"Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev. 2015;87:3\u201314.","journal-title":"Adv Drug Deliv Rev"},{"key":"10450_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.830420","volume":"12","author":"YZ Jia","year":"2022","unstructured":"Jia YZ, Liu J, Wang GQ, Song ZF. miR-484: A Potential Biomarker in Health and Disease. Front Oncol. 2022;12: 830420.","journal-title":"Front Oncol"},{"issue":"7","key":"10450_CR37","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1158\/1078-0432.CCR-19-0674","volume":"26","author":"N Li","year":"2020","unstructured":"Li N, Yang G, Luo L, Ling L, Wang X, Shi L, et al. lncRNA THAP9-AS1 Promotes Pancreatic Ductal Adenocarcinoma Growth and Leads to a Poor Clinical Outcome via Sponging miR-484 and Interacting with YAP. Clin Cancer Res. 2020;26(7):1736\u201348.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10450_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.7150\/ijbs.51123","volume":"17","author":"Z Huang","year":"2021","unstructured":"Huang Z, Xu Y, Wan M, Zeng X, Wu J. miR-340: A multifunctional role in human malignant diseases. Int J Biol Sci. 2021;17(1):236\u201346.","journal-title":"Int J Biol Sci"},{"issue":"9","key":"10450_CR39","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/tox.22938","volume":"35","author":"L Yan","year":"2020","unstructured":"Yan L, Yang S, Yue CX, Wei XY, Peng W, Dong ZY, et al. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells. Environ Toxicol. 2020;35(9):1015\u201328.","journal-title":"Environ Toxicol"},{"issue":"1","key":"10450_CR40","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1080\/21655979.2021.1959866","volume":"12","author":"Y Shuang","year":"2021","unstructured":"Shuang Y, Liu J, Niu J, Guo W, Li C. A novel circular RNA circPPFIA1 promotes laryngeal squamous cell carcinoma progression through sponging miR-340-3p and regulating ELK1 expression. Bioengineered. 2021;12(1):5220\u201330.","journal-title":"Bioengineered"},{"issue":"9","key":"10450_CR41","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.7150\/ijbs.70546","volume":"18","author":"W Wu","year":"2022","unstructured":"Wu W, Li Q, Zhu Z, Li C, Lu P, Zhou X, et al. HTR1D functions as a key target of HOXA10-AS\/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via PI3K-AKT signaling pathway. Int J Biol Sci. 2022;18(9):3777\u201394.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10450_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huang","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"key":"10450_CR43","doi-asserted-by":"crossref","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022.","DOI":"10.1093\/nar\/gkac194"},{"issue":"1","key":"10450_CR44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41416-020-01179-8","volume":"124","author":"I Khan","year":"2021","unstructured":"Khan I, Steeg PS. Endocytosis: a pivotal pathway for regulating metastasis. Br J Cancer. 2021;124(1):66\u201375.","journal-title":"Br J Cancer"}],"updated-by":[{"DOI":"10.1186\/s12885-023-10504-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10450-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-10450-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10450-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T06:04:26Z","timestamp":1672898666000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-10450-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10450"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-10450-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,26]]},"assertion":[{"value":"20 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12885-023-10504-2","URL":"https:\/\/doi.org\/10.1186\/s12885-023-10504-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The specimen collection procedure was approved by the Hospital Ethics Committee. The need for informed consent was waived by the Ethics Committee of Dongfang Hospital (IRB00006161\u2014Dongfang Hospital, Xiamen University). The investigation was approved by the Ethics Committee of Dongfang Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have declared that they have no competing interests and have confirmed its accuracy.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1354"}}